Date published: 2025-10-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α

0.0(0)
Write a reviewAsk a question

Molecular Weight:
458.5
Molecular Formula:
C24H33O5F3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

A lot of 17-phenyl trinor prostaglandin F2α (17-phenyl trinor PGF2α) derivatives have been approved for treatment of glaucoma(1,2,3). The ones where the 13,14-double bond has been hydrogenated retain good potency, but show a significantly reduced incidence of local irritant side effects(4). 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2α bears an aromatic ring which is reminiscent of the trifluoromethyl-phenoxy ring of travoprost ((+)-fluprostenol isopropyl ester). As an ocular hypotensive agent, it would be expected that 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2α would act like the free acid of latanoprost.


17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α References

  1. From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.  |  Stjernschantz, JW. 2001. Invest Ophthalmol Vis Sci. 42: 1134-45. PMID: 11328719
  2. The pharmacology of bimatoprost (Lumigan).  |  Woodward, DF., et al. 2001. Surv Ophthalmol. 45 Suppl 4: S337-45. PMID: 11434936
  3. Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents.  |  Resul, B., et al. 1993. J Med Chem. 36: 243-8. PMID: 8423596

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α, 1 mg

sc-223182
1 mg
$66.00

17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α, 5 mg

sc-223182A
5 mg
$300.00